首页> 外国专利> METHOD treatment of ischemic stroke

METHOD treatment of ischemic stroke

机译:方法治疗缺血性中风

摘要

1. A composition for the treatment of ischemic stroke, which is a solution for injectable administration, containing as active substance and auxiliary ubidekarenon dobavki.2. A composition according to claim 1, characterized in that the solution is sterilnym.3. A composition according to claim 1, characterized in that ubidekarenon used in solubilized forme.4. A composition according to claim 1, characterized in that as auxiliary additives are ascorbyl palmitate and / or sodium benzoate and / or citric kislotu.5. A method of treating an ischemic stroke, comprising injecting a pharmacologically effective amount ubidekarenona.6. A method according to claim 5, characterized in that the injection is intravenous administration vvedenie.7. A method according to claim 5, characterized in that in acute ischemic stroke patient is administered a composition according to claim 1 in the form of a single intravenous injection at a dose of 5-10 mg / kg.8. A method according to claim 5, characterized in that in acute ischemic stroke patient is administered a composition according to claim 1 as a double intravenous injection at a dose of 5-10 mg / kg in the acute period and after 6 hours after the first inektsii.9. A method according to claim 5, characterized in that in acute ischemic stroke patient is administered a composition according to claim 1 in the form of a single bolus intravenous injection at a dose of 5-10 mg / kg, followed by intravenous drip of 5-10 mg / kg 200 ml of saline through the first 2 hours after inektsii.10. A method according to claim 5, characterized in that in acute ischemic stroke patient is administered a composition according to claim 1 in the form of a single intravenous injection at a dose of 5-10 mg / kg with subsequent daily intravenous drip
机译:1.一种用于治疗缺血性中风的组合物,其为可注射给药的溶液,其含有作为活性物质和辅助的泛美肾上腺素dobavki。2。 2.根据权利要求1的组合物,其特征在于溶液是灭菌剂。 2.根据权利要求1的组合物,其特征在于在溶解的甲酸酯中使用了乌地卡伦酮。4。 2.根据权利要求1的组合物,其特征在于作为辅助添加剂的是抗坏血酸棕榈酸酯和/或苯甲酸钠和/或柠檬酸kislotu.5。一种治疗缺血性中风的方法,包括注射药理学有效量的泛肽肾上腺素。6。 6.根据权利要求5所述的方法,其特征在于,所述注射是静脉内注射vvedenie.7。 6.根据权利要求5的方法,其特征在于在急性缺血性中风患者中以5-10mg / kg的剂量以单次静脉内注射的形式给予根据权利要求1的组合物。 6.根据权利要求5所述的方法,其特征在于,在急性缺血性中风患者中,在急性期和第一次发作后6小时后,以5-10mg / kg的剂量向患者施用根据权利要求1的组合物,作为两次静脉内注射.9。 6.根据权利要求5的方法,其特征在于在急性缺血性中风患者中以5-10mg / kg的剂量单次推​​注静脉内注射形式给予根据权利要求1的组合物,然后静脉内滴注5- inektsii.10之后的前2个小时,应加入10 mg / kg 200 ml盐水。 6.根据权利要求5所述的方法,其特征在于,在急性缺血性中风患者中,以5-10mg / kg的剂量以单次静脉内注射的形式给予根据权利要求1的组合物,随后每日静脉滴注

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号